Polycythemia vera (NORD)

Polycythemia vera (NORD)

NBME - Hematoinmuno

NBME - Hematoinmuno

Cytokines
Complement system
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Tuberculosis: Pathology review
HIV and AIDS: Pathology review
Antiphospholipid syndrome
Cell-cell junctions
Atopic dermatitis
Contact dermatitis
Bullous pemphigoid
Pemphigus vulgaris
Stevens-Johnson syndrome
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Autoimmune hemolytic anemia
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Antimetabolites for cancer treatment
Topoisomerase inhibitors
Platinum containing medications
Monoclonal antibodies
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Microcytic anemia: Pathology review
Macrocytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Coagulation disorders: Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Hodgkin lymphoma
Non-Hodgkin lymphoma
Acute intermittent porphyria
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Porphyria cutanea tarda
Hemophilia
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Von Willebrand disease
Polycythemia vera (NORD)
Myelodysplastic syndromes
Myelofibrosis (NORD)
Langerhans cell histiocytosis

Transcript

Watch video only

In polycythemia vera, there are increased blood cell levels due to overproduction by the bone marrow, which is a soft tissue found within the bones.

Normally, about 45% of the total blood volume is made up of erythrocytes, or red blood cells, and their main function is to carry oxygen to tissues and bring carbon dioxide to the lungs so it can be expired. This value is called the hematocrit.

In polycythemia vera there’s an increase in red blood cell production.

It typically begins with a mutation in a single hematopoietic stem cell, which gives rise to red blood cells, white blood cells, and platelets.

In 90 percent of the affected individuals there is a mutation of the Janus Kinase 2 or JAK2 gene.

Normally, the kidneys produce erythropoietin which is a hormone that binds to receptors on the hematopoietic stem cells and activates JAK2 gene.

When that happens, it causes the cell to divide and thus produce more blood cells.

However, when there’s a mutation, it keeps JAK2 gene activated, and these cells are able to divide even in the absence of erythropoietin.

The mutated cells proliferate, and rapidly become the predominant hematopoietic cells in the bone marrow.

In time these cells start to die out and that’s when scar tissue forms.

At that point, the bone marrow can no longer produce blood cells, leading to anemia or low red blood cell levels, thrombocytopenia or low platelet levels, and leukopenia or low white blood cell levels. This is known as the spent phase.

And once the disease is in the spent phase, it’s really a different disease altogether - at that point it’s myelofibrosis.

The most common symptoms of polycythemia vera are fatigue, dizziness, increased sweating, redness in the face, blurred vision, and itchy skin especially after a hot shower.

Itchiness develops due to the increased number of basophils and mast cells which contain histamine that causes itching when released.

Splenomegaly or spleen enlargement is also common because the excess red blood cells buildup in the spleen, which usually helps with removing excess cells.

High turnover of red blood cells can cause build up of uric acid which leads to the inflammation of joints or gout and kidney stones.

Key Takeaways

Polycythemia vera is a bone marrow disorder in which there is an overproduction of blood cells, often caused by a JAK2 mutation within hematopoietic cells in the bone marrow. It can lead to elevated hemoglobin and hematocrit and predispose an individual to develop blood clots. Symptoms may include fatigue, weakness, headaches, dizziness, itching, and abdominal pain. Treatment may include medications to lower blood cell formation, and prevention of blood clots, phlebotomy, and radiation therapy.